Sign In
Buy STXS
$1.84
-0.130 (-6.60%)
At Close: Jun 03, 2026
Here's Why "Trend" Investors Would Love Betting on Stereotaxis Inc. (STXS)
09:54am, Tuesday, 29'th Jun 2021
If you are looking for stocks that are well positioned to maintain their recent uptrend, Stereotaxis Inc. (STXS) could be a great choice. It is one of the several stocks that passed through our "Recen
Could This Medical Device Stock Be the Next Big Growth Name?
11:43am, Wednesday, 09'th Jun 2021
Stereotaxis, Inc. (NYSE:STXS) produces robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures.
Stereotaxis Inc. (STXS) Soars 10%: Is Further Upside Left in the Stock?
06:46am, Wednesday, 09'th Jun 2021
Stereotaxis Inc. (STXS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term
What Makes Stereotaxis Inc. (STXS) a Good Fit for "Trend Investing"
09:47am, Tuesday, 08'th Jun 2021
Stereotaxis Inc. (STXS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Stereotaxis, Inc. (STXS) CEO David Fischel on Q1 2021 Results - Earnings Call Transcript
03:12pm, Monday, 10'th May 2021
Stereotaxis, Inc. (STXS) CEO David Fischel on Q1 2021 Results - Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates
11:16am, Monday, 10'th May 2021
Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 33.33% and 14.97%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Stereotaxis to Report First Quarter 2021 Financial Results on May 10, 2021
09:05am, Monday, 19'th Apr 2021
ST. LOUIS, April 19, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will rele
3 Catalysts For Stereotaxis That Have Investors Excited
12:22pm, Wednesday, 14'th Apr 2021
Stereotaxis will emerge from COVID-19 with higher recurring sales due to pent up demand for surgeries and greenfield system sales. The company's new proprietary catheter will increase recurring revenu
Broward Health Medical Center Becomes First Hospital in Florida to Adopt Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
09:00am, Wednesday, 07'th Apr 2021
ST. LOUIS, April 07, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Broward Health Med
5 Robotics Stocks on the Cutting Edge
08:15am, Wednesday, 17'th Mar 2021
Robotics stocks should have years of growth ahead as the trend toward automation continues. These 5 names aren't cheap, but look worth paying up for.
Stereotaxis Inc. (STXS) Moves 13.6% Higher: Will This Strength Last?
08:20am, Tuesday, 02'nd Mar 2021
Stereotaxis Inc. (STXS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow
Stereotaxis' (STXS) CEO David Fischel on Q4 2020 Results - Earnings Call Transcript
04:45am, Saturday, 27'th Feb 2021
Stereotaxis' (STXS) CEO David Fischel on Q4 2020 Results - Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Tops Revenue Estimates
11:25am, Thursday, 25'th Feb 2021
Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 0.00% and 15.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Stereotaxis Reports 2020 Full Year Financial Results
09:00am, Thursday, 25'th Feb 2021
ST. LOUIS, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results f
Stereotaxis Announces Long-Term CEO Performance Stock Award
04:05pm, Wednesday, 24'th Feb 2021
ST. LOUIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a 10-year CEO perf
